LOBULAR BREAST CARCINOMA IN SITU

This adverse event was reported 95 times

These drugs are most commonly taken by patients reporting LOBULAR BREAST CARCINOMA IN SITU:

# Drug Count
0 ERGOCALCIFEROL 9
1 RANITIDINE 9
2 LEVONORGESTREL 7
3 OCRELIZUMAB 7
4 ESCITALOPRAM 6
5 ESCITALOPRAM OXALATE 6
6 ESCITSLOPRAM 6
7 LANSOPRAZOLE 6
8 LENALIDOMIDE 6
9 METHOTREXATE 6
See all common drugs associated with LOBULAR BREAST CARCINOMA IN SITU

LOBULAR BREAST CARCINOMA IN SITU is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 ANTI-FUNGAL MICONAZOLE ATHLETES FOOT SPRAY TALC FREE 1 0.0007
1 JOCK ITCH SPRAY 1 0.0007
2 TERBUTALINE SULFATE 1 0.0005
3 ATOVAQUONE 4 0.0005
4 CICLOPIROX 1 0.0004
5 DEFLAZACORT 1 0.0004
6 BARICITINIB 1 0.0003
7 ERGOCALCIFEROL 9 0.0003
8 ACETAMINOPHEN AND DIPHENHYDRAMINE HCL 1 0.0003
9 DEXTROMETHORPHAN HYDROBROMIDE, BUPROPION HYDROCHLORIDE 1 0.0003
See all drugs enriched for association with LOBULAR BREAST CARCINOMA IN SITU